ARCHIVES

Grantees Not In Danger Of Losing Cost-Free Biological Materials, But Can’t Have Chemicals

This article is from The Cancer Letter archive.

Vol. 03 No. 36 | September 9, 1977

Download PDF Visit The Full Archive

Related Articles

Ceritinib Demonstrates 58% ORR, 7-month PFS in ALK+ NSCLC

March 28, 2014

DCPC Board Agrees to Commit $62 Million To Trials Of Prostate, Lung, Colorectal Cancer Screening

October 20, 1989

NCI Clarifies IRPG Application Receipt, Funding Policies

September 3, 1993

Coalition Gives “Incomplete” To NCI, CDC Statistics, But Gets Low Grade From Critics

March 20, 1998

Phase II Study Cohort Fails To Overcome Erlotinib Resistance

April 26, 2013

In Brief: Michael Friedman to Retire as CEO of City of Hope

March 1, 2013